Literature DB >> 15540514

Neuropsychological development of children born to patients with systemic lupus erythematosus.

F Neri1, L Chimini, F Bonomi, E Filippini, M Motta, D Faden, A Lojacono, C Biasini Rebaioli, M Frassi, E Danieli, A Tincani.   

Abstract

To verify the neuropsychological development in the offspring of patients with systemic lupus erythematosus (SLE), 47 children (23 male and 24 female) from affected women were studied. The tests applied were related to the children's ages: Griffiths scale up to four years, WPPSI and metaphonological tests (MP, evaluating the phonological consciousness) from four to six years of age, WISC-R test and Rey test (evaluating the visual-space abilities) from six years onwards; finally, specific tests for the diagnosis of learning disabilities (LD) between the ages of seven and 13. Intelligence levels were always normal (mean IQ score 106.32; median 104; SD 9.05). Three out of eight examined children failed MP, therefore may develop LD and will need further evaluation later. Fourteen children were specifically studied for LD and three reported scores lower than normal, but only two (who were brothers) were defined dyslexic. Antiphospholipid antibodies (aPL) were positive in the mothers of the three children with impaired LD tests. Other maternal autoantibodies or drugs administered during pregnancy did not seem to be related to LD. In conclusion, maternal SLE does not impair intelligence levels, but may increase the occurrence of LD particularly in male children (2/8 males examined, 25%). Both maternal aPL and genetic background may have pathogenetic implications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15540514     DOI: 10.1191/0961203304lu2018oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  18 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Lupus and pregnancy: complex yet manageable.

Authors:  Josephine Patricia Dhar; Robert J Sokol
Journal:  Clin Med Res       Date:  2006-12

4.  Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Authors:  Cynthia Aranow; Betty Diamond; Meggan Mackay
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 5.  Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.

Authors:  B Diamond; O Bloom; Y Al Abed; C Kowal; P T Huerta; B T Volpe
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 6.  Lessons from an anti-DNA autoantibody.

Authors:  Joel Cohen-Solal; Betty Diamond
Journal:  Mol Immunol       Date:  2011-01-07       Impact factor: 4.407

Review 7.  Neonatal effects of maternal antiphospholipid syndrome.

Authors:  Angela Tincani; Chiara Biasini Rebaioli; Laura Andreoli; Andrea Lojacono; Mario Motta
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 8.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

Review 9.  To B or not to B cells-mediate a healthy start to life.

Authors:  T G Nguyen; C M Ward; J M Morris
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

10.  In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus.

Authors:  Wendy Marder; Martha A Ganser; Vivian Romero; Margaret A Hyzy; Caroline Gordon; W J McCune; Emily C Somers
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.